https://pipelinereview.com/intellia-therapeutics-announces-fda-clearance-of-investigational-new-drug-ind-application-for-ntla-2002-an-in-vivo-crispr-based-investigational-therapy-for-the-treatment-of-hereditary-angioedema-hae/